Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.
Hina
H
Takano
Kaoru
K
Nagata
Michiaki
M
Mikoshiba
Minoru
M
Nakane
Atsushi
A
Kato
Hiroyuki
H
Hamaguchi
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D006362:Heavy Chain Disease / Q000188:drug therapy; D006801:Humans; D007142:Immunoglobulin gamma-Chains; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007142:Immunoglobulin gamma-Chains; D011344:Procarbazine; D000069283:Rituximab; D005047:Etoposide; D003520:Cyclophosphamide; D011241:Prednisone